Takeshi Kurosu

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Clinical course and virologic dynamics of Mpox during tecovirimat treatment: Prospective multicenter case series in Japan.

Clinical course and virologic dynamics of Mpox during tecovirimat treatment: Prospective multicenter case series in Japan.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: May 19, 2026

Hantavirus L protein exhibits shutoff activity mediated by its N-terminal endonuclease domain.

Hantavirus L protein exhibits shutoff activity mediated by its N-terminal endonuclease domain.

Journal: Scientific reports

Published: January 30, 2026

Efficacy of favipiravir treatment for patients with severe fever with thrombocytopenia syndrome assessed with a historical control.

Efficacy of favipiravir treatment for patients with severe fever with thrombocytopenia syndrome assessed with a historical control.

Journal: Antimicrobial agents and chemotherapy

Published: October 17, 2025

Trace amounts of cobalt serve as an adjuvant for unglycosylated JEV-ED3 expressed in E. coli, inducing a potent virus-neutralizing immune response.

Trace amounts of cobalt serve as an adjuvant for unglycosylated JEV-ED3 expressed in E. coli, inducing a potent virus-neutralizing immune response.

Journal: Vaccine

Published: September 02, 2025

Efficient whole-genome sequencing of Monkeypox virus using a novel nuclease-multiple displacement amplification enrichment method.

Efficient whole-genome sequencing of Monkeypox virus using a novel nuclease-multiple displacement amplification enrichment method.

Journal: Npj viruses

Published: August 31, 2025

Neutralizing antibodies against the Japanese encephalitis virus are produced by a 12 kDa E. coli- expressed envelope protein domain III (EDIII) tagged with a solubility-controlling peptide.

Neutralizing antibodies against the Japanese encephalitis virus are produced by a 12 kDa E. coli- expressed envelope protein domain III (EDIII) tagged with a solubility-controlling peptide.

Journal: Vaccine

Published: January 08, 2025

Selective TLR ligand stimulation enhances in vivo mosquito-borne flavivirus pathogenicity.

Selective TLR ligand stimulation enhances in vivo mosquito-borne flavivirus pathogenicity.

Journal: Cell reports

Published: October 10, 2024

Cytokine storm and vascular leakage in severe dengue: insights from single-cell RNA profiling.

Cytokine storm and vascular leakage in severe dengue: insights from single-cell RNA profiling.

Journal: Life science alliance

Published: August 21, 2024

Altered neutrophil responses to dengue virus serotype three: delayed apoptosis is regulated by stabilisation of Mcl-1.

Altered neutrophil responses to dengue virus serotype three: delayed apoptosis is regulated by stabilisation of Mcl-1.

Journal: Scientific reports

Published: May 30, 2024

N-glycosylation of viral glycoprotein is a novel determinant for the tropism and virulence of highly pathogenic tick-borne bunyaviruses.

N-glycosylation of viral glycoprotein is a novel determinant for the tropism and virulence of highly pathogenic tick-borne bunyaviruses.

Journal: PLoS pathogens

Published: February 11, 2024

Severe fever with thrombocytopenia syndrome (SFTS) in Thailand: using a one health approach to respond to novel zoonosis and its implications in clinical practice.

Severe fever with thrombocytopenia syndrome (SFTS) in Thailand: using a one health approach to respond to novel zoonosis and its implications in clinical practice.

Journal: One health outlook

Published: February 01, 2024

Mice, myeloid cells, and dengue: a new model for unraveling vascular leakage mysteries.

Mice, myeloid cells, and dengue: a new model for unraveling vascular leakage mysteries.

Journal: Frontiers in microbiology

Published: January 09, 2024

Showing 1-12 of 81

Last Updated: 09/26/2026